Most G protein-coupled receptors (GPCRs) recruit b-arrestins and are internalized upon agonist 15 stimulation. For the µ-opioid receptor (µ-OR), this process has been linked to development of opioid 16 tolerance. GPCR kinases (GRKs), particularly GRK2 and GRK3, have been shown to be important for 17 µ-OR recruitment of b-arrestin and internalization. However, the contribution of GRK2 and GRK3 to 18 b-arrestin recruitment and receptor internalization, remain to be determined in their complete 19 absence. By CRISPR/Cas9 we established HEK293 cells with knock-out of GRK2, GRK3 or both to 20 dissect their individual contributions in b-arrestin2 recruitment and µ-OR internalization upon 21 stimulation with four different agonists. We showed that GRK2/3 removal reduced agonist-induced 22 µ-OR internalization substantially. Furthermore, we found GRK2 to be more important for µ-OR 23 internalization than GRK3. In contrast, the effect of GRK2/3 knock-out on b-arrestin2 recruitment 24 was minor. Rescue expression experiments restored GRK2/3 functions. The GRK2/3 small molecule 25 inhibitor CMPD101 showed a high similarity between the genetic and pharmacological approaches, 26 cross-validating the specificity of both. However, off-target effects were observed at high CMPD101 27
Bias towards b-arrestin2 recruitment vs. internalization in DGRK2/3 cells 152
To assess whether a bias between µ-OR internalization and b-arrestin2 recruitment was 153 detectable in the genome-edited cells compared to the parental cells, we calculated the differences 154 between the transduction coefficients ( Fig. 4) . These calculations showed a significant bias towards 155 b-arrestin2 recruitment in the DGRK2/3 cells compared to the parental cells, when stimulated with 156 DAMGO or loperamide. When calculating the bias for morphine or fentanyl-stimulated cells, no 157 significance was obtained between the cell lines due to higher variation. Yet, a tendency towards b-158 arrestin2 recruitment bias was observed for fentanyl-stimulated µ-ORs in all the genome-edited 159 cells compared to the parental cells. This analysis is consistent with the larger reductions in 160 internalization than in b-arrestin2 recruitment that we observed upon deleting GRK2 and/or -3. 161 162
Similar effects of genetic deletion and pharmacological inhibition of GRK2/3 163
The small molecule inhibitor CMPD101 has been shown to selectively inhibit GRK2/3 over GRK1 and 164 GRK5 in vitro 27 . We compared the internalization and b-arrestin recruitment results obtained in the 165 DGRK2/3 cells with that obtained using the kinase inhibitor. At CMPD101 concentrations £ 10 µM, 166
we observed no effect on receptor internalization in absence of agonist (basal internalization) ( Fig.  167 5a) or basal b-arrestin2 recruitment (Fig. 5e ) in the parental HEK293A and DGRK2/3 cells. With 168 DAMGO stimulation in the parental cells, we found a concentration dependent decrease in µ-OR 169 internalization plateauing at a level similar to the DGRK2/3 cells with an IC50 of 1.8 µM (pIC50 = 5.79 170 ± 0.12) ( Fig. 5b) and in b-arrestin2 recruitment with an IC50 of 0.73 µM (pIC50 = 6.13 ± 0.14) at 9 0.059, paired t-test). Thus, in this concentration range CMPD101 specifically inhibits GRK2/3 and 174 reaches inhibition comparable to the DGRK2/3 cell line at 10 µM. 175
At CMPD101 concentrations ³ 30 µM decreases in basal and DAMGO-stimulated µ-OR 176 internalization were found both in parental and DGRK2/3 cells ( Fig. 5a,b) . Basal b-arrestin2 177 recruitment was increased at CMPD101 concentrations ³ 30 µM in parental and DGRK2/3 cells, 178 whereas no further effects were observed on DAMGO-induced recruitment at high CMPD101 179 concentrations ( Fig. 5e,f) . µ-OR surface expression was similar in the parental and DGRK2/3 cells in 180 the internalization experiments ( Fig. 5c ) and 25% higher in the DGRK2/3 cells in the b-arrestin2 181 recruitment experiments ( Fig. 5g) . Due to the long-lifetime donor fluorophore with several emission 182 peaks and the homogenous format, the internalization assay is sensitive to compounds that absorb 183 light in most of the visual spectrum. However, the donor signal in absence of acceptor was 184 unaffected by CMPD101 even at concentrations ³ 30 µM ( Fig. 5d) , demonstrating that the observed 185 effects at high concentrations were not due to optical interference with the internalization assay. 186
We conclude that CMPD101 at concentrations above ≥ 30 µM has a non-GRK2/3 regulatory effect 187 on basal µ-OR b-arrestin2 recruitment and internalization and DAMGO-stimulated µ-OR 188 internalization. 189
190

Discussion 191
Compelling evidence on the importance of GRKs in µ-OR pharmacology has increased over the 192
years. Yet, most of these studies has relied on methods either overexpressing dominant negative 193 forms of the protein of interest or silencing with siRNAs, possibly leading to undesired effects of 194 overexpression or incomplete removal of the target protein 33 . Genome editing is a promising 195 alternative to these approaches for investigating their role as potential modulators of GPCR 196 function. In this study we have generated genome-edited HEK293 cells and used them to dissect the 197 role of GRK2 and GRK3 in µ-OR internalization and b-arrestin2 recruitment. 198
Previous studies have demonstrated that GRK2 and GRK3 affect the phosphorylation state of 199 the 375 STANT 379 motif in mouse µ-OR 19,20,23 , and this region has been directly linked to the regulation 200 of µ-OR internalization by mutational studies 20,21 . Here, we demonstrate that our DGRK2, DGRK3 201 and DGRK2/3 cell lines are excellent novel tools to dissect the role of these GRK subtypes in DAMGO, 202 fentanyl and loperamide-induced µ-OR internalization. Double KO of GRK2/3 had an additive effect 203 on µ-OR internalization with a significant reduction for DAMGO, fentanyl and loperamide-induced 204 µ-OR internalization. No statistically significant difference could be reached for morphine-induced 205 µ-OR internalization, however this agonist induces low µ-OR internalization and thereby the effects 206 could be masked by the small assay window. Our study also shows that there are additional factors 207 controlling µ-OR internalization, since deletion of GRK2/3 did not fully inhibit µ-OR internalization. 208
There is limited evidence suggesting that GRK5 or GRK6 could be responsible for this: µ-OR 209 internalization is sensitive to GRK5 and GRK6 overexpression 13,22 and GRK5 has been shown to be 210 important in HEK293 cells and mouse brain for morphine-induced phosphorylation of Ser375 23 , 211 which is a critical residue in initiating further C-terminal µ-OR phosphorylation 20 . In contrast, 212 DAMGO-induced phosphorylation of the C-terminal region of µ-OR was shown to be unaffected by 213 knockdown of GRK5 and GRK6 20,23 and fentanyl-induced Ser375 phosphorylation was unchanged in 214 mice lacking GRK5 12 , so the roles of GRK5 and GRK6 might depend on the GRK expression levels in 215 an individual cell. Several other kinases and enzymes have been proposed to regulate µ-OR 216 internalization, including phospholipase D2 (PLD2) and protein kinase C (PKC) 5 , but more studies are 217 required to determine their role relative to the GRKs. Our successful generation of the DGRK2, 218 DGRK3 and DGRK2/3 cell lines demonstrate the utility in this approach and calls for generation of additional cell lines with KO of other kinases to dissect other contributors to µ-OR internalization in 220 the future. 221
Since agonist-induced µ-OR internalization was shown to be fully dependent on the presence of 222 b-arrestins ( Fig. 2) , we speculated that b-arrestin2 recruitment likewise would be affected by 223 GRK2/3 removal. Surprisingly, b-arrestin2 recruitment was not significantly reduced for any of the 224 agonist stimulations in the DGRK2 and/or -3 cells ( Fig. 3, Table 2 ). b-arrestin2 recruitment was 225 actually increased slightly but significantly in DGRK3 cells when stimulated with DAMGO, which is 226 likely due to competition of GRK3 with GRK2 or another kinase that is more efficient at inducing b-227 arrestin2 recruitment. Treating the parental cells with the small molecule GRK2/3 inhibitor, 228 CMPD101, showed a similar tendency upon stimulation with DAMGO, namely 60% reduction in 229 internalization and only 25% reduction for b-arrestin2 recruitment (Fig. 5b,f) . Previous studies have 230 shown, that alanine substitutions of serine and threonine residues in the 375 STANT 379 motif lead to 231 a reduction in the agonist-mediated b-arrestin2 recruitment 21,34 , and that residues in this motif are 232 specifically phosphorylated by GRK2 and GRK3 20,23,34 . Since this study was performed on the 233 unmodified µ-OR, it cannot be excluded that there could occur redundant phosphorylation by other 234 kinases, as the µ-OR has been described to be phosphorylated by many different kinases 5 , and 235 thereby retain the b-arrestin2 recruitment. While most of the studies mentioned above used the 236 mouse µ-OR, the human µ-OR was used in this study. However, the STANT motif is fully conserved 237 in human µ-OR and the G protein activation and b-arrestin recruitment properties are very similar 238 for mouse and human µ-OR 24,35 , so species differences are unlikely to explain the observed 239
differences. 240
The predominant paradigm of arrestin binding to a GPCR is a two-step model where a pre-241 complex is formed by binding of arrestin to the phosphorylated GPCR C-tail, followed by major 242 conformational changes in arrestin leading to a high affinity interaction with the core of the receptor 243 7TM bundle [36] [37] [38] [39] [40] . Different arrestin conformations can result from this encounter depending on the 244 receptor, agonist and the available kinases 41-44 and the arrestin conformation correlates with the 245 trafficking properties of the receptor 44 . Accordingly, we hypothesize, that full phosphorylation of 246 the µ-OR is necessary in order for b-arrestin to be recruited and undergo the full conformational 247 change to mediate receptor internalization, as µ-OR internalization is dramatically reduced in the 248 DGRK2/3 cells, however b-arrestin2 might still be able to be recruited to a partially phosphorylated 249 µ-OR but not undergo the full activation necessary to mediate internalization. It should be noted 250 that although our study shows that GRK2 and GRK3 are not necessary for recruitment of b-arrestin2 251 in HEK293 cells, our rescue experiments here and in a previous study 24 Although using CRISPR/Cas9 genome editing to generate cell lines lacking specific proteins has 264 several advantages over conventional methods for interrogating protein function, it has also been 265 criticized for potentially selecting clones that have compensated for the lack of the deleted 266 protein 50 . We addressed this concern by transient expression of the deleted proteins and by 267 pharmacological inhibition with CMPD101. Transient expression of GRK2 or GRK3 showed that µ-268 OR in the genome-edited cells was still sensitive to regulation by GRK2 and GRK3. Comparison with 269 pharmacological inhibition is an alternative way to characterize genome-edited cells if a specific and 270 potent inhibitor exists. We compared the µ-OR internalization and b-arrestin2 recruitment in the 271 DGRK2/3 cells with the effect of the inhibitor CMPD101 on the parental cells and found highly similar 272 results. Collectively, these results demonstrate that there are no significant compensatory 273 mechanisms in the DGRK2/3 cells of relevance to the µ-OR functions studied here and confirms the 274 utility of CMPD101 as a GRK2/3 selective pharmacological tool in concentrations up to 10 µM. Our 275 DGRK2/3 cells also proved to be a powerful tool to study specificity of GRK inhibitors as we could 276 demonstrate off-target effects of CMPD101 at concentrations ≥ 30 µM, which is a concentration 277 range commonly used to inhibit GRK2/3 28,34 , thus cautioning the use of such high concentrations in 278 future studies. 279
In conclusion, we have generated novel DGRK2, DGRK3 and DGRK2/3 cell lines in the highly 280 utilized HEK293A cell background. These cell lines complement the range of G protein and b-arrestin 281 cell lines generated by Dr. Asuka Inoue 51 and thus expand this highly efficient tool box to study 282 intracellular proteins involved in GPCR function and signaling. Here, we demonstrate the utility of 283 the cell lines to study µ-OR mediated b-arrestin2 recruitment to the cell membrane and µ-OR 284 internalization, but we envision that the cell lines could be used for a range of other studies and 285 thus welcome all requests to obtain the DGRK2, DGRK3 and DGRK2/3 cell lines for future studies. for cloning by incubating 100 µM of reverse complementary strands with T4 PNK in a thermocycler 340 at 37 °C for 30 minutes followed by a 5-minute incubation at 95 °C and ramping down to 25 °C with 341
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Figure legends
In all comparisons to the reference WT, samples from the genome-edited cells were located on the 627 same blot and treated equally to the reference WT. (b) Quantification of anti-GRK2 and anti-GRK3 628 western blots after normalization to the GAPDH signal. Mean ± SEM of 3-7 independent 
